NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
申请人:Yoshida Tomohiro
公开号:US20100228026A1
公开(公告)日:2010-09-09
The invention provides a sulfonyl malonamide derivative, or a pharmacologically acceptable salt thereof or a solvate thereof, that has therapeutic and/or preventive effect(s) on various diseases due to its agonist action at AT
2
receptor, and is useful as a pharmaceutical agent for the treatment and/or prevention of diseases involving the renin-angiotensin-aldosterone system (RAAS).
Leistungsgesteigerte und irritationsverminderte Mittel zum Aufhellen und/oder Färben von Keratinfasern, insbesondere menschlichen Haaren, enthalten -bezogen auf ihr Gewicht - 0,001 bis 15 Gew.-% mindestens eines Tetrazols. Vorzugsweise sind darüber hinaus 0,001 bis 5 Gew.-% eines oder mehrerer Oxidationsfarbstoffvorprodukte und/oder direktziehender Farbstoffe enthalten.
QUAST H.; BIEBER L.; MEICHSNER G., LIEBIGS ANN. CHEM.,(1987) N 5, 469-475
作者:QUAST H.、 BIEBER L.、 MEICHSNER G.
DOI:——
日期:——
MEDICAMENT FOR SUPPRESSING MALIGNANT TUMOR METASTASIS
申请人:NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
公开号:US20170014419A1
公开(公告)日:2017-01-19
Provided are a novel medicament for suppressing or preventing the metastasis of a malignant tumor such as carcinoma, a novel treatment or prevention method for suppressing or preventing the metastasis of a malignant tumor, etc. The medicament comprises a non-peptidic angiotensin type 2 receptor agonist as an active ingredient. In the medicament, the non-peptidic angiotensin type 2 receptor agonist may be, for example, a sulfonyl malonamide compound. The medicament may be a medicament for use in combination with an anticancer agent and/or an antitumor agent.